Gene · 2931
Papers2,889
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,889
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Virtual Screening and Testing of GSK-3 Inhibitors Using Human SH-SY5Y Cells Expressing Tau Folding Reporter and Mouse Hippocampal Primary Culture under Tau Cytotoxicity. | Biomol Ther (Seoul) | 2023 | 35790892 | PubTator, text mining | PubMed |
| Proteogenomic characterization of cholangiocarcinoma. | Hepatology | 2023 | 35716043 | PubTator, text mining | PubMed |
| Chemical composition and therapeutic mechanism of Xuanbai Chengqi Decoction in the treatment of COVID-19 by network pharmacology, molecular docking and molecular dynamic analysis. | Mol Divers | 2023 | 35258759 | PubTator, text mining | PubMed |
| Beyond its Psychiatric Use: The Benefits of Low-dose Lithium Supplementation. | Curr Neuropharmacol | 2023 | 35236261 | PubTator, text mining | PubMed |
| Deficiency of Parkinson's Related Protein DJ-1 Alters Cdk5 Signalling and Induces Neuronal Death by Aberrant Cell Cycle Re-entry. | Cell Mol Neurobiol | 2023 | 35182267 | PubTator, text mining | PubMed |
| Dysregulated Protein Phosphorylation as Main Contributor of Granulovacuolar Degeneration at the First Stages of Neurofibrillary Tangles Pathology. | Neuroscience | 2023 | 34757172 | PubTator, text mining | PubMed |
| p110α activity at the M-to-G1 transition is critical for cellular proliferation and reentry into the cell cycle. | Turk J Biol | 2022 | 37529255 | PubTator, text mining | PubMed |
| Oncoproteomic profiling of AML: moving beyond genomics. | Expert Rev Proteomics | 2022 | 36734985 | PubTator, text mining | PubMed |
| Sponging Away Cardiac Injury: A Natural Compound Shows Cardioprotective Promise. | JACC Basic Transl Sci | 2022 | 36687272 | PubTator, text mining | PubMed |
| Circulating microRNAs Showed Specific Responses according to Metabolic Syndrome Components and Sex of Adults from a Population-Based Study. | Metabolites | 2022 | 36676927 | PubTator, text mining | PubMed |
| Identification of immune- and autophagy-related genes and effective diagnostic biomarkers in endometriosis: a bioinformatics analysis. | Ann Transl Med | 2022 | 36660690 | PubTator, text mining | PubMed |
| Therapeutic Potency of Induced Pluripotent Stem-Cell-Derived Corneal Endothelial-like Cells for Corneal Endothelial Dysfunction. | Int J Mol Sci | 2022 | 36614165 | PubTator, text mining | PubMed |
Hydroxy-α-sanshool isolated from Zanthoxylum bungeanum Maxim. has antidiabetic effects on high-fat-fed and streptozotocin-treated mice via increasing glycogen synthesis by regulation of PI3K/Akt/GSK-3β/GS signaling. | Front Pharmacol | 2022 | 36582530 | PubTator, text mining | PubMed |
| Proteomics of the dentate gyrus reveals semantic dementia specific molecular pathology. | Acta Neuropathol Commun | 2022 | 36578035 | PubTator, text mining | PubMed |
| Proteomics and Phospho-Proteomics Profiling of the Co-Formulation of Type I and II Interferons, HeberFERON, in the Glioblastoma-Derived Cell Line U-87 MG. | Cells | 2022 | 36552831 | PubTator, text mining | PubMed |
| Sex differences in early and term placenta are conserved in adult tissues. | Biol Sex Differ | 2022 | 36550527 | PubTator, text mining | PubMed |
| Targets and mechanisms of Alpinia oxyphylla Miquel fruits in treating neurodegenerative dementia. | Front Aging Neurosci | 2022 | 36533181 | PubTator, text mining | PubMed |
| Inhibition of glycogen synthase kinase-3-beta (GSK3β) blocks nucleocapsid phosphorylation and SARS-CoV-2 replication. | Mol Biomed | 2022 | 36508083 | PubTator, text mining | PubMed |
| Inhibition of glycogen synthase kinase 3 by lithium, a mechanism in search of specificity. | Front Mol Neurosci | 2022 | 36504683 | PubTator, text mining | PubMed |
| Recent Advances in the Digestive, Metabolic and Therapeutic Effects of Farnesoid X Receptor and Fibroblast Growth Factor 19: From Cholesterol to Bile Acid Signaling. | Nutrients | 2022 | 36500979 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2931/papers?page=16